The safe use of medication and the adherence to treatment are significant public health challenges where understanding, access to accurate information, and trust play major roles.
The Innovative Medicines Initiative (IMI) project Gravitate Health aims to develop digital health tools to improve access of patients and healthcare professionals to trusted information on medicines and care plans.
i~HD leads a work package focused on the pilot studies and their evaluation, to derive the evidence on how delivering better quality medication and health information to patients through mobile technologies can impact on their understanding of their medication, adherence to it and health outcomes. We are also contributing to the business modelling and long term sustainability strategy.
About Gravitate Health
40 leading partners from civil society, academia and industry in 15 countries have joined forces to develop these novel, patient-focussed healthcare information tools.
The project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 945334. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations [EFPIA]. The total budget is 18.5 M€ for a project duration of 60 months.
